Fractional Flow Reserve Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
The fractional flow reserve market is expected to register a CAGR of 13.2% during the forecast period due to higher prevalence of cardiovascular diseases and emerging trends in product.
Key HighlightsNorth America expected to hold a major market share in the fractional flow reserve market due to the increasing geriatric population and associated cardiovascular diseases. According to the Center for Disease Control and Prevention, in 2016, approximately 26.2 million people were diagnosed with heart disease and coronary artery disease is the most diagnosed heart disease in United States. Also, according to the American Heart Association, the incidence rate of heart attack is around 720,000 annually. Hence, these factors are expected to propel the fractional flow reserve market growth.
Fractional Flow Reserve Market Competitive AnalysisThe market is fragmented and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Strategic initiatives taken by companies to develop the product is expected to boost market growth. For instance, in 2019, Koninklijke Philips NV launched an IntraSight Interventional applications platform that offers iFR, FFR, and IVUS solution. Some of the companies that are currently dominating the market are Opsens Medical, Abbott, Boston Scientific, GE Healthcare, Siemens Healthcare, Cathworks, Medis Medical Imaging System, Pie Medical Imaging BV, Heartflow Inc., and Koninklijke Philips NV.
Additional Benefits:Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook